ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ, ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ LAVIPHARM Α.Ε. valuation

Bring your own price

Enter a share price and a discount rate — every multiple recomputes on the spot from ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ, ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ LAVIPHARM Α.Ε.'s latest ESEF (IFRS) filing. Change either input and the page follows.

ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ, ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ LAVIPHARM Α.Ε. reports in EUR, so every figure here is in EUR as filed — enter its home-market share price in EUR (not a USD ADR quote) so the multiples line up. The prefilled discount rate is a USD starting point; for a EUR intrinsic value, override it with a EUR rate. Ratios (P/E, EV/EBITDA, P/S, P/B) are currency-neutral.

Share price (EUR)

€

Discount rate (% per year)

Enter a share price to run the model.

Build a firmer per-company rate with the cost-of-equity and WACC calculators, then paste it here.

Share price — · awaiting your input

Market Capitalization

Equity value at your price

—

Enterprise Value

Market cap + debt − cash

—

Price-to-Earnings

P/E · Trailing Diluted

—

Earnings Yield

EPS ÷ Price · Trailing

—

Price-to-Free-Cash-Flow

P/FCF · Trailing

—

Free-Cash-Flow Yield

FCF Yield · Trailing

—

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing

—

Enterprise-Value-to-Sales

EV/Sales · Trailing

—

Price-to-Sales

P/S · Trailing

—

Price-to-Book

P/B · Latest filing

—

Methodology

All multiples are computed in your browser from your share price and ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ, ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ LAVIPHARM Α.Ε.'s IFRS fundamentals (ifrs-full:Revenue, ProfitLoss, Assets, Equity, DilutedEarningsLossPerShare, …) as tagged in its ESEF annual report (source: filings.xbrl.org). Figures are in EUR. Nothing on this page is a market quote, and it is not investment advice.